Skip to content

Effect of heparin in the treatment of recurrent IVF–ET Failure

Effect of heparin in the treatment of recurrent IVF–ET Failure

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT138807202575N1
Enrollment
100
Registered
2010-10-02
Start date
2009-04-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility and IVF failure. female infertility

Interventions

Intervention 1: Heparin, 5000 IU, subcutaneous, twice a day, from embryo transfer to 6 weeks after delivery. Intervention 2: No intervention.
Treatment - Drugs
Heparin, 5000 IU, subcutaneous, twice a day, from embryo transfer to 6 weeks after delivery
No intervention

Sponsors

Shahid Sodoughi Medical Science University, Yazd Research and Clinical Center for Infertility
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : Pervious failure of IVF cycle at least for three times, age 19-35 years old, BMI = 19- 29, FSH < 10 IU/L, good embryo quality, presence of both ovaries Exclusion criteria: Presence of PCOS, presence of hydrosalpinx or endometriosis, presence of uterine abnormality, contraindication for heparin, presence of chronic renal, thyroid, or liver diseases, presence of thrombocytopenia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Chemical pregnancy. Timepoint: on day 14 after IVF. Method of measurement: BHCG.

Secondary

MeasureTime frame
Clinical pregnancy. Timepoint: 2 weeks after positive pregnancy test. Method of measurement: detected of FHR by ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehri Mashayekhy

Yazd Research and Clinical Center for Infertility

Dr.Mashayekhy@gmail.com dr.mashayekhy@yahoo.com+98 35 1824 7085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 9, 2026